Bolt Total Stockholder Equity from 2010 to 2025
| BOLT Stock | USD 0.49 0.02 3.92% |
Total Stockholder Equity | First Reported 2010-12-31 | Previous Quarter 129.7 M | Current Value 67.4 M | Quarterly Volatility 92.9 M |
Check Bolt Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bolt Biotherapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 7.5 M, Interest Income of 7.5 M or Depreciation And Amortization of 2.5 M, as well as many indicators such as Price To Sales Ratio of 5.87, Dividend Yield of 0.0 or PTB Ratio of 0.35. Bolt financial statements analysis is a perfect complement when working with Bolt Biotherapeutics Valuation or Volatility modules.
Bolt | Total Stockholder Equity |
Latest Bolt Biotherapeutics' Total Stockholder Equity Growth Pattern
Below is the plot of the Total Stockholder Equity of Bolt Biotherapeutics over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Bolt Biotherapeutics' Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bolt Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
| Total Stockholder Equity | 10 Years Trend |
|
Total Stockholder Equity |
| Timeline |
Bolt Total Stockholder Equity Regression Statistics
| Arithmetic Mean | 27,321,062 | |
| Coefficient Of Variation | 340.08 | |
| Mean Deviation | 74,351,460 | |
| Median | (15,943,000) | |
| Standard Deviation | 92,914,632 | |
| Sample Variance | 8633.1T | |
| Range | 355.1M | |
| R-Value | 0.57 | |
| Mean Square Error | 6237.6T | |
| R-Squared | 0.33 | |
| Significance | 0.02 | |
| Slope | 11,136,962 | |
| Total Sum of Squares | 129496.9T |
Bolt Total Stockholder Equity History
About Bolt Biotherapeutics Financial Statements
Bolt Biotherapeutics shareholders use historical fundamental indicators, such as Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Bolt Biotherapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Bolt Biotherapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Bolt Biotherapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Stockholder Equity | 129.7 M | 67.4 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bolt Stock Analysis
When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.